We found that similar to male mice, Cdkl5 activity increases during AKI in females, and genetic or pharmacological inhibition of Cdkl5 function provides protection from ischemia and cisplatin-associated AKI (Supplementary Figs. 24 and 25). The gene discussed is CDKL5; the disease is acute kidney injury.